These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8180337)

  • 1. A new variant of interaction between phospholipid antibodies and the protein C system.
    Bokarewa MI; Blombäck M; Egberg N; Rosén S
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):37-41. PubMed ID: 8180337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on phospholipid antibodies, APC-resistance and associated mutation in the coagulation factor V gene.
    Bokarewa MI; Bremme K; Falk G; Sten-Linder M; Egberg N; Blombäck M
    Thromb Res; 1995 May; 78(3):193-200. PubMed ID: 7631299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipid antibodies and resistance to activated protein C in women with thrombophilia.
    Bokarewa MI; Blombäck M; Bremme K
    Blood Coagul Fibrinolysis; 1995 Jul; 6(5):417-22. PubMed ID: 8589207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies.
    Membre A; Wahl D; Latger-Cannard V; Max JP; Lacolley P; Lecompte T; Regnault V
    Haematologica; 2008 Apr; 93(4):566-73. PubMed ID: 18322249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated protein C resistance phenotype in patients with antiphospholipid antibodies.
    Aznar J; Villa P; España F; Estellés A; Grancha S; Falcó C
    J Lab Clin Med; 1997 Aug; 130(2):202-8. PubMed ID: 9280148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon.
    Rand JH; Wu XX; Andree HA; Ross JB; Rusinova E; Gascon-Lema MG; Calandri C; Harpel PC
    Blood; 1998 Sep; 92(5):1652-60. PubMed ID: 9716593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated protein C resistance in patients with anti-beta 2 glycoprotein I antibodies.
    Martinuzzo M; Forastiero R; Adamczuk Y; Cerrato G; Carreras LO
    Blood Coagul Fibrinolysis; 1996 Oct; 7(7):702-4. PubMed ID: 8958393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
    Nojima J; Kuratsune H; Suehisa E; Iwatani Y; Kanakura Y
    Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosus.
    Nojima J; Kuratsune H; Suehisa E; Kawasaki T; Machii T; Kitani T; Iwatani Y; Kanakura Y
    Br J Haematol; 2002 Aug; 118(2):577-83. PubMed ID: 12139749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C.
    de Laat B; Eckmann CM; van Schagen M; Meijer AB; Mertens K; van Mourik JA
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):757-64. PubMed ID: 19002041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of beta 2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitro.
    Keeling DM; Wilson AJ; Mackie IJ; Isenberg DA; Machin SJ
    J Clin Pathol; 1993 Oct; 46(10):908-11. PubMed ID: 8227406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticardiolipin antibodies do not seem to be associated with APC resistance in vivo or in vitro.
    Tsakiris DA; Yasikoff ML; Wolf F; Marbet GA
    Ann Hematol; 1995 Oct; 71(4):195-8. PubMed ID: 7578527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant.
    Pötzsch B; Kawamura H; Preissner KT; Schmidt M; Seelig C; Müller-Berghaus G
    J Lab Clin Med; 1995 Jan; 125(1):56-65. PubMed ID: 7822946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies are not present in the membrane of gel-filtered platelets of patients with IgG anticardiolipin antibodies, lupus anticoagulant and thrombosis.
    Biasiolo A; Pengo V
    Blood Coagul Fibrinolysis; 1993 Jun; 4(3):425-8. PubMed ID: 8329568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibody: functional specificity for inhibition of prothrombin activation by the prothrombinase complex.
    Pierangeli SS; Goldsmith GH; Branch DW; Harris EN
    Br J Haematol; 1997 Jun; 97(4):768-74. PubMed ID: 9217175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. True anti-anionic phospholipid immunoglobulin M antibodies can exert lupus anticoagulant activity.
    Gallart T; Benito C; Reverter JC; Bosch F; Blay M; Tàssies D; Vigorito E; Cervera R; Font J; Gomis R; Campo E; Vives J
    Br J Haematol; 2002 Mar; 116(4):875-86. PubMed ID: 11886395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.